The company said it did not receive any observations from USFDA for its Moraiya facility, indicating successful resolution of the warning letter and thereby expects major boost to its US business.
first published: Feb 16, 2017 03:46 pm
A collection of the most-viewed Moneycontrol videos.

Live: Sensex, Nifty rangebound on monthly expiry day | Closing Bell

Live: Will Nifty's downtrend continue to third session on expiry day? | Opening Bell

Nifty Slips Below 26,100 Amid Sluggish Trade, Midcaps Struggle; IT Lends Support | Closing Bell Live

Live: Can Nifty reach its all-time high levels this week? | Opening Bell
You are already a Moneycontrol Pro user.

